A Study Of TL-925 For The Treatment of AC

Clinical trial NCT06293820 · COMPLETED

Trial details

NCT number: NCT06293820
Sponsor: Telios Pharma, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Allergic Conjunctivitis

Start date: 2024-04-11
Primary completion: 2024-05-21
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.